BRCA1 and cancer: The discovery of BRCA1 and BRCA2 gene pathogenic variants has made it possible to identify high oncologic risk populations and improve their life expectancy with individualized screenings, early cancer diagnosis, novel therapies and prophylactic procedures [1].